Joint venture combines PREMIA’s regional clinical-genomic infrastructure with Lind’s evidence-driven AI platform to accelerate patient identification for multinational trials TAIPEI and SAN MATEO, Calif. – Precision Medicine Asia, Limited (PREMIA) …
Copyright © CB Herald. 2026
